-+ 0.00%
-+ 0.00%
-+ 0.00%

Elephas Biosciences to present new ex vivo immunotherapy response study data at SITC 2026

PUBT·10/06/2026 14:07:26
Listen to the news
Elephas Biosciences to present new ex vivo immunotherapy response study data at SITC 2026
  • Elephas Biosciences outlined new ex vivo immunotherapy response data for presentation at the Society for Immunotherapy of Cancer meeting on Nov. 6.
  • The work links immune characteristics in live tumor fragments from routine biopsies with whether samples respond to checkpoint inhibitors ex vivo.
  • Elephas also scheduled live demonstrations of its elive Edge tissue-cutting device at booth 1035 during the Nov. 4-8 meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elephas Biosciences Corp. published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.